Ian Carruthers - Bioquell Plc Independent Non-Executive Director

Director

Sir Ian Carruthers.OBE is an Independent NonExecutive Director of Bioquell PLC., since August 2010. He Joined the Board in August 2010. He is former Chief Executive of the NHS South of England and has extensive experience of the UK and international healthcare systems. He is a Chairman of Portsmouth Hospitals NHS Trust, Chancellor of the University of West of England and Chair of Healthcare UK. since 2010.
Tenure 14 years
Phone44 1264 835 835
Webhttp://www.bioquellplc.com

Bioquell Plc Management Efficiency

The company has return on total asset (ROA) of 6.36 % which means that it generated a profit of $6.36 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 12.0 %, meaning that it generated $12.0 on every $100 dollars invested by stockholders. Bioquell Plc's management efficiency ratios could be used to measure how well Bioquell Plc manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Robert ManzoVisteon Corp
61
Joanne MaguireVisteon Corp
65
Mark ZupanConstellation Brands Class
54
Till WilmschenWallbox NV
N/A
Jean SharpeVector Group
73
Ernesto HernandezConstellation Brands Class
63
Harry WilsonVisteon Corp
46
Susan JohnsonConstellation Brands Class
54
Keith WandellConstellation Brands Class
69
James LockeConstellation Brands Class
78
James BarreseVisteon Corp
50
Paul CarlucciVector Group
72
Kristopher DoyleVisteon Corp
N/A
Suresh GarimellaModine Manufacturing
56
Christy ClarkConstellation Brands Class
54
Eric AshlemanModine Manufacturing
54
David AndersonModine Manufacturing
71
Charles CooleyModine Manufacturing
64
Christine YanModine Manufacturing
55
Stanley ArkinVector Group
82
Jennifer DanielsConstellation Brands Class
57
Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and is traded on OTC Market. It employs 220 people. Bioquell Plc [BIQLF] is traded as part of a regulated electronic trading bulletin board offered by the NASD.

Management Performance

Bioquell Plc Leadership Team

Elected by the shareholders, the Bioquell Plc's board of directors comprises two types of representatives: Bioquell Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioquell. The board's role is to monitor Bioquell Plc's management team and ensure that shareholders' interests are well served. Bioquell Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioquell Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director
Simon Constantine, Independent Non-Executive Director

Bioquell Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Bioquell Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bioquell Plc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioquell Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioquell Plc will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to DTE Energy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DTE Energy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DTE Energy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DTE Energy to buy it.
The correlation of DTE Energy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DTE Energy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DTE Energy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DTE Energy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Bioquell OTC BB Equity

If you are still planning to invest in Bioquell Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioquell Plc's history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments